The results of the studies described in this communication indicate that antimicrobials cause suppression of normal aerobic and anaerobic flora in a variety of ways. In conclusion, it is summarized that: (i) Changes in the intestinal microflora are the reflection of the antibacterial spectrum and activity specific to the antibiotic administered. (ii) Degrees of alteration in the flora correlate well to concentrations of drug in the intestinal contents, and particularly, with the antibiotics of parenteral administration, they depend on the concentrations excreted in the bile. (iii) Changes in the flora take place within 24 hr of drug administration , and at least 2 weeks and usually 3 to 4 weeks are required for recovery of flora to normal levels . (iv) When bacteria that harbor R plasmids mediating resistance to the antibiotic used exist in the flora, the drug is inactivated, resulting in selective overgrowth of the resistant organisms. After withdrawal of the drug the resistant organisms may disappear or decrease in number. (v) Bifidobacteria are generally very sensitive to most of the antibiotics tested. (vi) Overgrowth of yeasts is seen during the course of drug administration.
It is my great honor and privilege, as the first speaker in this Symposium, to present the studies of myself and my colleagues.
In this paper we will discuss studies on the In the earlier studies, only coliform bacteria were used as indicator organisms to follow up such disturbances in the flora. It has, however, become a recent trend to study the alteration in both aerobic and anaerobic bacteria (2, (6) (7) (8) (9) . A variety of aims are possible for studies on the alteration of the intestinal flora resulting from administration of antimicrobial agents. Table 1 . Subjects, routes, and dosages for administration of antimicrobial agents studied tion of substances produced in the colon. (vi) Determination of the effects on the host's mechanisms of defense against infection. The purpose of this report is to present a summarized review of our studies on the effects of antimicrobial agents on the aerobic and anaerobic flora in human and animal feces as listed in Table 1 . The experimental methods used in these studies are those exclusively established by Mitsuoka et al. (4).
Cephalosporins
Cefazolin (CEZ): Two beagle dogs were intravenously injected with 200 mg of CEZ per kg of body weight per day for 30 days (CEZ-200 group). Two dogs that were not given the drug served as controls. Stool specimens from these animals were analysed for both aerobic and anaerobic bacteria. The effects of CEZ treatment on the total flora and individual bacterial groups are shown in Fig. 1 . A 2.5-fold decrease in total flora was observed in the CEZ-200 group compared with the control group. This modest difference is accounted for by the elimination of Eubacteria and Peptococcaceae and the dramatic suppression of Bacteroides, Bifidobacteria and Lactobacilli in the CEZ-200 group.
In contrast, Streptococci showed a 5-fold increase, while Enterobacteriaceae decreased 16-fold. When total flora is divided into aerobes and anaerobes, the significant difference seen was a 10-4.7 decrease in total anaerobic organisms in the CEZ-200 group.
With respect to detection frequency, there was a consistent tendency for loss of anaerobic bacteria in the CEZ-200 group.
Cefazolin and cefoxitin (CFX): Twelve beagle dogs were divided equally into 4 groups. One group received no antibiotic agent, another group received 80 mg of CEZ per kg per day (CEX-80 group), and the third and fourth groups were given 80 and 400 mg of CFX per kg per day, respectively (CFX-80 and CFX-400 groups) . The drugs were intravenously injected into the animals for 14 days. The effects of CEZ and CFX on the intestinal flora were observed by examination of the stool specimens obtained on the day before the treatment had begun (day 0 of study), on days 2, 8, and 15 of study during the treatment period, and on days 22, 29, 36, and 43 of study in the period the drugs were withdrawn. Figure 2 were strikingly decreased or eliminated one day after the administration began (day 2 of study), except for Streptococci which were reduced only slightly in number (1/16 of the count on day 0 of study). The suppression of flora was seen to continue during the treatment period , although a sign of recovery of the flora to normal was observed at the end of treatment (day 15 of study). In particular , bacteria belonging to the Enterobacteriaceae group increased to the level existing prior to treatment. After withdrawal of CEZ , counts of most of the bacterial groups gradually increased to normal within 3 weeks and almost complete recovery was seen 4 weeks after the end of drug administration. Similar alterations in fecal flora were observed in the CFX-80 and CFX-400 groups. Time sequence changes in the mean log counts of flora in the CFX-400 group are shown in Fig. 3 . On day 2 of study all of the anaerobes were eliminated, while Streptococci showed a 126-fold de- crease which represented the total flora. Bacteria belonging to the Enterobacteriace and Lactobacillus groups, and yeasts as well as Streptococci tended to increase during the treatment period, whereas other bacterial groups were suppressed until a week after the withdrawal of CFX. The amounts of CEZ and CFX excreted into the bile of beagle dogs were monitored (data not shown). By 8 hr after intravenous injection, 4.1 % of CEZ was recovered in the CEZ-80 group, whereas 1.0% of CFX was recovered in the CFX-400 group. These results well account for the suppression of flora in the stool specimens obtained one day after drug administration. The degrees of suppression of flora observed in the two groups were almost identical. It is indicated that this is due to the presence of comparable concentrations of both drugs in the intestinal contents of the animals used.
SM-1652, a new cephalosporin: The subjects studied were healthy adult male human volunteers (subjects No. 16, 17, and 18). Fecal specimens were collected prior to administration of the drug (day 0 of study) and on days 2, 4, and 7 of study into the treatment period, and at 1 and 2 weeks after the end of treatment. All three subjects received intravenously a single dose of 1 g of SM-1652 (Sumitomo Chemical Co., Osaka, and Yamanouchi Pharmaceutical Co., Tokyo) per day for 6 days. Stool specimens were analysed for aerobic and anaerobic bacteria. Fecal levels of the drug were also determined for all three subjects during the treatment period (R. Nakaya, T. Chida, H. Shibaoka, and H. Sagara, Jpn. J. Bacteriol. 36: 370, 1981; Manuscripts submitted to Chemotherapy).
SM-1652 caused drastic suppression of normal aerobic and anaerobic flora in subjects No. 16 and 17 on days 3 and 2 of study after the administration of the drug, respectively, and most of the organisms were eliminated within the treatment period. Typical changes observed in subject No. 17 are shown in ' the upper panels of Fig. 4 . The changes in flora in subject No. 17 were similar to, but more striking than, those in the beagle dogs treated with CEZ and CFX as mentioned previously. All the bacteria , in the intestinal flora were strongly suppressed on day 2 of study (one day after the first injection of SM-1652) , and then eliminated over the administration period until 1 week after the withdrawal of the drug . It is noteworthy that only yeasts showed overgrowth during the administration period, and accounted for the total counts of flora .
Overgrowth of yeasts was also recognized in the other two subjects. The significant difference was the drastic suppression of Streptococci and Enterobacteriaceae in subject No. 17 throughout the administration period compared with the results seen in the beagle dogs treated with CEZ and CFX . It is suggested that such a difference is accounted for by the antibacterial spectrum specific for each drug as well as by the concentration of drug in the intestinal contents. In the lower panels of Fig . 4 Bacteroides vulgatus. Figure  6 shows the pres- (ii) These resistant organisms almost com-pletely inactivated SM-1652 excreted into the intestinal tract during treatment and showed a selective overgrowth in flora and comprised the most predominant bacterial group during the administration period. Two groups of cynomolgus monkeys, five in each group, were used to observe the effect of SM-1652 on intestinal flora. One group received intravenous injections of 600 mg per kg body weight per day for 24 weeks. Stool specimens from these animals were tested for aerobic and anaerobic bacteria at the 12th and 24th week of the administration period. The other group not given the drug served as a control. As shown in Fig. 7 , a pronounced suppression of anaerobic flora was recognized in the experimental groups, particularly 12 weeks into the treatment period, as compared to the control group. In contrast, Enterobacteriaceae and yeasts showed a significant increase, while Lactobacilli and Streptococci remained unchanged. Cefoperazone (CPZ): CPZ is one of the cephalosporin antibiotics that exhibits a potent activity to Pseudomonas aeruginosa and Gram-negative enteric bacteria (3) . A study design similar to that of an SM-1652 study was used to reveal the effect of CPZ on human and beagle dog intestinal flora (Manuscripts in preparation). Three adult male volunteers (subjects A, B, and C) were given intravenous injections of 1 g of CPZ, 2 times daily, for 5.5 days. The changes in the flora of these subjects were essentially similar to those described for subjects No. 16 and 17 treated with SM-1652. Figure 8 depicts the data of subject A as a representative example. The fecal CPZ concentrations at 1 and 5 days after starting drug administration reached 2 and 3.5 mg per gram of stool, respectively, as presumed by its excretion in the bile (5) . The aerobic and the anaerobic bacteria were eliminated to below the detection level, while only yeasts showed an overgrowth. Recovery of flora to normal levels was seen at 13 days after cessation of CPZ administration.
The effects of CPZ on fecal flora were also investigated in beagle dogs by intra- venous as well as intramuscular injections. In Fig. 9 are shown the data of experiments on intravenous injection. A total of 10 beagle dogs were assigned to 4 groups, each consisting of 2 or 3 animals: 3 groups were given intravenous injections of 100, 200, and 33: 262, 1978) . The animals (3 in each group) were intravenously injected with 50 and 500 mg of each antibiotic per kg body weight per day for 15 days. Both drugs significantly suppressed anaerobic flora but not aerobic bacteria. In these experiments , it was observed that the rabbits of the experimental groups lost body weight and died of diarrhea. It is known that penicillins exhibit effects toxic to rabbits and guinea pigs. This was also confirmed in this study. Daiichi Seiyaku Co., Tokyo) are chemically synthesized, oral antibac- Table 2 . Effects of piperacillin and ampicillin on the intestinal microflora of beagle dogs (6) 
Pipemidic Acid and DJ-6783

Panfuran S
Panfuran S (PFS, dihydroxym.ethylfuratrizine, Toyama Chemical Co., Tokyo) is a synthetic antibacterial drug which has a broad spectrum. PFS treatment was performed on 11 adult patients with diseases of the urinary tract who were required to be treated with chemotherapeutic agents prior to or after surgical operations. A dose of either 250 or 500 mg, 4 times a day, was administered to the subjects for 3 days (R. 
Clioquinol
We have previously reported that patients suffering from subacute myelo-optic neuropathy (SMON) show marked abnormalities in fecal flora, presumably due to the administration of clioquinols (Cli) (7). Cli are synthetic antibacterial drugs that have been widely used for treatment and prophylaxis of mild gastrointestinal disorders, but it is now established that these drugs cause SMON. Table 4 shows the results of our investigations on the fecal flora of SMON patients as compared to those of normal subjects (7), indicating remarkable alterations in the flora of SMON patients. Table 4 . Fecal flora in normal subjects and SMON patientsa (7) penicillin T-1220 on the intestinal microflora in dogs. Igaku-no-Ayumi 101: 773-775. 
